FDA Inspection 1107044 — Research Institute of Central Florida
The FDA completed an inspection of Research Institute of Central Florida on September 30, 2019 in Winter Park, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 30, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Winter Park, FL (United States)
Additional Details
Clinical BA/BE